Toll Free: 1-888-928-9744

Sinovac Biotech Ltd. - Product Pipeline Review - 2016

Published: Sep, 2016 | Pages: 32 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Sinovac Biotech Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Sinovac Biotech Ltd. - Product Pipeline Review - 2016', provides an overview of the Sinovac Biotech Ltd.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Sinovac Biotech Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Sinovac Biotech Ltd.
- The report provides overview of Sinovac Biotech Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Sinovac Biotech Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Sinovac Biotech Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Sinovac Biotech Ltd.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Sinovac Biotech Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Sinovac Biotech Ltd.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Table of Contents


Table of Contents 2
List of Tables 4
List of Figures 4
Sinovac Biotech Ltd. Snapshot 5
Sinovac Biotech Ltd. Overview 5
Key Facts 5
Sinovac Biotech Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Sinovac Biotech Ltd. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Sinovac Biotech Ltd. - Pipeline Products Glance 14
Sinovac Biotech Ltd. - Clinical Stage Pipeline Products 14
Phase I Products/Combination Treatment Modalities 14
Sinovac Biotech Ltd. - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combination Treatment Modalities 15
Preclinical Products/Combination Treatment Modalities 16
Sinovac Biotech Ltd. - Drug Profiles 17
(measles + mumps + rubella) vaccine - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
chickenpox vaccine - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
coxsackievirus [serotype A16] vaccine - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
diphtheria + pertussis(acellular) + tetanus vaccine - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
haemophilus influenzae B vaccine - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
hepatitis A + hepatitis B vaccine - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
hepatitis B vaccine - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
influenza [strain A/H7N9] vaccine - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
polio vaccine - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
rabies vaccine - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
rotavirus vaccine - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
Sinovac Biotech Ltd. - Pipeline Analysis 28
Sinovac Biotech Ltd. - Pipeline Products by Molecule Type 28
Sinovac Biotech Ltd. - Dormant Projects 29
Sinovac Biotech Ltd. - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30

Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 31
Disclaimer 32
List of Tables

Sinovac Biotech Ltd., Key Facts 5
Sinovac Biotech Ltd. - Pipeline by Indication, 2016 8
Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2016 9
Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2016 10
Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2016 11
Sinovac Biotech Ltd. - Partnered Products in Pipeline, 2016 12
Sinovac Biotech Ltd. - Partnered Products/ Combination Treatment Modalities, 2016 13
Sinovac Biotech Ltd. - Phase I, 2016 14
Sinovac Biotech Ltd. - IND/CTA Filed, 2016 15
Sinovac Biotech Ltd. - Preclinical, 2016 16
Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2016 28
Sinovac Biotech Ltd. - Dormant Developmental Projects,2016 29
Sinovac Biotech Ltd., Subsidiaries 30 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify